Recruiting

Suicide Prevention Intervention

Sponsor:

University of Washington

Code:

NCT06499740

Conditions

Suicide Prevention

Eligibility Criteria

Sex: All

Age: 10+

Healthy Volunteers: Not accepted

Interventions

Pilot Intervention

Treatment as Usual

Study Details

Brief summary:

Suicide is a leading cause of death among adolescents in the United States and improving access to high quality just-in-time suicide interventions to reduce risk has important public health implications. Integrating such interventions into routinely accessed settings, such as pediatric primary care, holds promise; however, many clinicians in these settings fail to adequately screen or intervene in youth suicidal thoughts and behaviors, representing a key barrier to reducing suicide. The proposed study is a pre-post quasi-experimental pilot feasibility and preliminary efficacy trial of a suicide prevention intervention informed by evidence based interventions including the SAFETY-Acute suicide prevention intervention implemented in 3 pediatric primary care clinics.

Conditions

Suicide Prevention

Study ID

NCT06499740

Start date

May 4, 2026

Status verified date

Jul, 2026

Completion date

Mar, 2028

Anticipated

Primary completion date

Oct, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 10+

Healthy Volunteers: Not accepted

Adolescent Inclusion Criteria:

  • adolescent between the ages of 10 and 18 years old
  • speaks fluent English
  • current or recent suicide risk

Adolescent Exclusion Criteria:

  • high suicide risk (in need of immediate crisis stabilization services such as inpatient medical or psychiatric hospitalization)
  • does not speak fluent English
  • does not have a primary care provider

Caregiver Inclusion Criteria:

  • has a child who meets inclusion criteria
  • Age 18 years or older

Caregiver Exclusion Criteria:

  • does not have a child who meets inclusion criteria
  • does not speak English

Provider Inclusion Criteria:

  • Age 18 years or older
  • works in primary care/outpatient healthcare setting

Study Design

Enrollment

48 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

active comparator: Treatment as usual

Arm 1 entails months 1-2 of this study. Treatment as usual will be delivered by providers to adolescent patients in their clinics during the first two months of this study. Treatment as usual will be defined by each individual clinic based on their existing clinic protocols.

experimental: Pilot Intervention

Arm 2 entails months 3-4 of this study. Participating providers will deliver the adapted pilot intervention for the second half (months 3-4) of the pilot trial. The intervention will be based on the evidence-based suicide prevention interventions including the SAFETY-Acute protocol and will be adapted based on information from potential users prior to piloting. It is anticipated that both adolescent patients and their parents/caregivers will be involved in the intervention. Anticipated components of the intervention include psychoeducation, coping skills, safety planning, lethal means restriction, parenting skills, communication skills, identifying adolescent and family strengths, and linking to longer term care.

Interventions

Pilot Intervention

This intervention is a suicide prevention intervention that will be adapted from evidence-based suicide prevention interventions including the SAFETY-Acute program. The specific intervention components will be determined from information gathered in this study but the investigators anticipate will include components such as identifying strengths, coping skills, safety planning, lethal means restriction, psychoeducation, motivation building, and care linkage.

Treatment as Usual

Treatment as usual delivered in participating clinics.

Primary outcome measure

  • Feasibility of Intervention Measure [ Time Frame: Participant and providers complete approximately 2 weeks after completing intervention ]
  • Acceptability of Intervention Measure [ Time Frame: Participant and providers complete approximately 2 weeks after completing intervention ]
  • Intervention Appropriateness Measure [ Time Frame: Participant and providers complete approximately 2 weeks after completing intervention ]
  • Client Satisfaction Questionnaire [ Time Frame: Participant completes approximately 2 weeks after completing intervention ]
  • Intervention Usability Scale [ Time Frame: Provider completes approximately 2 weeks after completing intervention ]

Central Contacts and Locations

Central contacts

Sarah Danzo, PhD

206-987-1786sdanzo@uw.edu

Locations

Northwest Pediatrics

Recruiting

Centralia, Washington, United States, 98531

Contacts

Lily Lo, MD

(360) 736-6778llo@nwpeds.com

Richmond Pediatrics

Recruiting

Mountlake Terrace, Washington, United States, 98043

Contacts

Melissa Walsh, MD

(206) 546-2421melissa.walsh@seattlechildrens.org

Olympia Pediatrics

Recruiting

Olympia, Washington, United States, 98506

Contacts

Janelle Tiegs

(360) 413-8470JanelleT@olypeds.com

More Information

Sponsor

University of Washington

Last update posted

Jul 16, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Washington on 2026-07-16.